APO Research
Talk to an analyst

APO RESEARCH · REPORT

Phenprocoumon

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Phenprocoumon Market Analysis and Forecast 2026-2032

20 December 2025193 pages

Choose your research edition.

Industry ResearchPhenprocoumon Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Phenprocoumon Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Phenprocoumon Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Phenprocoumon Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Phenprocoumon Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Phenprocoumon market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Phenprocoumon is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Phenprocoumon is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Phenprocoumon is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Phenprocoumon is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Phenprocoumon include Teva, Novartis, Mylan, Roche, Wörwag Pharma, Divis Labs, Aspen Pharmacare and Acis Arzneimittel, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Phenprocoumon, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Phenprocoumon, also provides the sales of main regions and countries. Of the upcoming market potential for Phenprocoumon, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Phenprocoumon sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Phenprocoumon market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Phenprocoumon sales, projected growth trends, production technology, application and end-user industry.

Phenprocoumon Segment by Company

Teva

Novartis

Mylan

Roche

Wörwag Pharma

Divis Labs

Aspen Pharmacare

Acis Arzneimittel

Phenprocoumon Segment by Type

5 mg

10 mg

25 mg

50 mg

Phenprocoumon Segment by Application

Pulmonary Embolism

Venous Thrombosis

Thromboembolism

Others

Phenprocoumon Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Phenprocoumon market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Phenprocoumon and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Phenprocoumon.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Phenprocoumon in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Phenprocoumon manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Phenprocoumon sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Phenprocoumon Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 5 mg Major Manufacturers Table 3. 10 mg Major Manufacturers Table 4. 25 mg Major Manufacturers Table 5. 50 mg Major Manufacturers Table 6. Global Phenprocoumon Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Pulmonary Embolism Major Manufacturers Table 8. Venous Thrombosis Major Manufacturers Table 9. Thromboembolism Major Manufacturers Table 10. Others Major Manufacturers Table 11. Phenprocoumon Industry Trends Table 12. Phenprocoumon Industry Drivers Table 13. Phenprocoumon Industry Opportunities and Challenges Table 14. Phenprocoumon Industry Restraints Table 15. Global Phenprocoumon Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Phenprocoumon Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Phenprocoumon Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Phenprocoumon Revenue Market Share by Region (2021-2026) Table 19. Global Phenprocoumon Revenue Market Share by Region (2027-2032) Table 20. Global Phenprocoumon Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 21. Global Phenprocoumon Sales by Region (2021-2026) & (K Units) Table 22. Global Phenprocoumon Sales by Region (2027-2032) & (K Units) Table 23. Global Phenprocoumon Sales Market Share by Region (2021-2026) Table 24. Global Phenprocoumon Sales Market Share by Region (2027-2032) Table 25. Global Phenprocoumon Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Phenprocoumon Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Phenprocoumon Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Phenprocoumon Sales Market Share by Manufacturers (2021-2026) Table 29. Global Phenprocoumon Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 30. Global Phenprocoumon Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Phenprocoumon Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Phenprocoumon Manufacturers, Product Type & Application Table 33. Global Phenprocoumon Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Phenprocoumon by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Phenprocoumon Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Phenprocoumon Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Phenprocoumon Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Phenprocoumon Revenue Market Share by Type (2021-2026) Table 40. Global Phenprocoumon Revenue Market Share by Type (2027-2032) Table 41. Global Phenprocoumon Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 42. Global Phenprocoumon Sales by Type (2021-2026) & (K Units) Table 43. Global Phenprocoumon Sales by Type (2027-2032) & (K Units) Table 44. Global Phenprocoumon Sales Market Share by Type (2021-2026) Table 45. Global Phenprocoumon Sales Market Share by Type (2027-2032) Table 46. Global Phenprocoumon Price by Type (2021-2026) & (US$/Unit) Table 47. Global Phenprocoumon Price by Type (2027-2032) & (US$/Unit) Table 48. Global Phenprocoumon Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Phenprocoumon Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Phenprocoumon Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Phenprocoumon Revenue Market Share by Application (2021-2026) Table 52. Global Phenprocoumon Revenue Market Share by Application (2027-2032) Table 53. Global Phenprocoumon Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 54. Global Phenprocoumon Sales by Application (2021-2026) & (K Units) Table 55. Global Phenprocoumon Sales by Application (2027-2032) & (K Units) Table 56. Global Phenprocoumon Sales Market Share by Application (2021-2026) Table 57. Global Phenprocoumon Sales Market Share by Application (2027-2032) Table 58. Global Phenprocoumon Price by Application (2021-2026) & (US$/Unit) Table 59. Global Phenprocoumon Price by Application (2027-2032) & (US$/Unit) Table 60. Teva Company Information Table 61. Teva Business Overview Table 62. Teva Phenprocoumon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 63. Teva Phenprocoumon Product Portfolio Table 64. Teva Recent Development Table 65. Novartis Company Information Table 66. Novartis Business Overview Table 67. Novartis Phenprocoumon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Novartis Phenprocoumon Product Portfolio Table 69. Novartis Recent Development Table 70. Mylan Company Information Table 71. Mylan Business Overview Table 72. Mylan Phenprocoumon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Mylan Phenprocoumon Product Portfolio Table 74. Mylan Recent Development Table 75. Roche Company Information Table 76. Roche Business Overview Table 77. Roche Phenprocoumon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Roche Phenprocoumon Product Portfolio Table 79. Roche Recent Development Table 80. Wörwag Pharma Company Information Table 81. Wörwag Pharma Business Overview Table 82. Wörwag Pharma Phenprocoumon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Wörwag Pharma Phenprocoumon Product Portfolio Table 84. Wörwag Pharma Recent Development Table 85. Divis Labs Company Information Table 86. Divis Labs Business Overview Table 87. Divis Labs Phenprocoumon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Divis Labs Phenprocoumon Product Portfolio Table 89. Divis Labs Recent Development Table 90. Aspen Pharmacare Company Information Table 91. Aspen Pharmacare Business Overview Table 92. Aspen Pharmacare Phenprocoumon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Aspen Pharmacare Phenprocoumon Product Portfolio Table 94. Aspen Pharmacare Recent Development Table 95. Acis Arzneimittel Company Information Table 96. Acis Arzneimittel Business Overview Table 97. Acis Arzneimittel Phenprocoumon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Acis Arzneimittel Phenprocoumon Product Portfolio Table 99. Acis Arzneimittel Recent Development Table 100. North America Phenprocoumon Revenue by Type (2021-2026) & (US$ Million) Table 101. North America Phenprocoumon Revenue by Type (2027-2032) & (US$ Million) Table 102. North America Phenprocoumon Sales by Type (2021-2026) & (K Units) Table 103. North America Phenprocoumon Sales by Type (2027-2032) & (K Units) Table 104. North America Phenprocoumon Sales Price by Type (2021-2026) & (US$/Unit) Table 105. North America Phenprocoumon Sales Price by Type (2027-2032) & (US$/Unit) Table 106. North America Phenprocoumon Revenue by Application (2021-2026) & (US$ Million) Table 107. North America Phenprocoumon Revenue by Application (2027-2032) & (US$ Million) Table 108. North America Phenprocoumon Sales by Application (2021-2026) & (K Units) Table 109. North America Phenprocoumon Sales by Application (2027-2032) & (K Units) Table 110. North America Phenprocoumon Sales Price by Application (2021-2026) & (US$/Unit) Table 111. North America Phenprocoumon Sales Price by Application (2027-2032) & (US$/Unit) Table 112. North America Phenprocoumon Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. North America Phenprocoumon Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 114. North America Phenprocoumon Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 115. North America Phenprocoumon Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 116. North America Phenprocoumon Sales by Country (2021-2026) & (K Units) Table 117. North America Phenprocoumon Sales by Country (2027-2032) & (K Units) Table 118. North America Phenprocoumon Sales Price by Country (2021-2026) & (US$/Unit) Table 119. North America Phenprocoumon Sales Price by Country (2027-2032) & (US$/Unit) Table 120. United States Phenprocoumon Revenue (2021-2032) & (US$ Million) Table 121. Canada Phenprocoumon Revenue (2021-2032) & (US$ Million) Table 122. Europe Phenprocoumon Revenue by Type (2021-2026) & (US$ Million) Table 123. Europe Phenprocoumon Revenue by Type (2027-2032) & (US$ Million) Table 124. Europe Phenprocoumon Sales by Type (2021-2026) & (K Units) Table 125. Europe Phenprocoumon Sales by Type (2027-2032) & (K Units) Table 126. Europe Phenprocoumon Sales Price by Type (2021-2026) & (US$/Unit) Table 127. Europe Phenprocoumon Sales Price by Type (2027-2032) & (US$/Unit) Table 128. Europe Phenprocoumon Revenue by Application (2021-2026) & (US$ Million) Table 129. Europe Phenprocoumon Revenue by Application (2027-2032) & (US$ Million) Table 130. Europe Phenprocoumon Sales by Application (2021-2026) & (K Units) Table 131. Europe Phenprocoumon Sales by Application (2027-2032) & (K Units) Table 132. Europe Phenprocoumon Sales Price by Application (2021-2026) & (US$/Unit) Table 133. Europe Phenprocoumon Sales Price by Application (2027-2032) & (US$/Unit) Table 134. Europe Phenprocoumon Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. Europe Phenprocoumon Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 136. Europe Phenprocoumon Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 137. Europe Phenprocoumon Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 138. Europe Phenprocoumon Sales by Country (2021-2026) & (K Units) Table 139. Europe Phenprocoumon Sales by Country (2027-2032) & (K Units) Table 140. Europe Phenprocoumon Sales Price by Country (2021-2026) & (US$/Unit) Table 141. Europe Phenprocoumon Sales Price by Country (2027-2032) & (US$/Unit) Table 142. Germany Phenprocoumon Revenue (2021-2032) & (US$ Million) Table 143. France Phenprocoumon Revenue (2021-2032) & (US$ Million) Table 144. U.K. Phenprocoumon Revenue (2021-2032) & (US$ Million) Table 145. Italy Phenprocoumon Revenue (2021-2032) & (US$ Million) Table 146. Netherlands Phenprocoumon Revenue (2021-2032) & (US$ Million) Table 147. China Phenprocoumon Revenue by Type (2021-2026) & (US$ Million) Table 148. China Phenprocoumon Revenue by Type (2027-2032) & (US$ Million) Table 149. China Phenprocoumon Sales by Type (2021-2026) & (K Units) Table 150. China Phenprocoumon Sales by Type (2027-2032) & (K Units) Table 151. China Phenprocoumon Sales Price by Type (2021-2026) & (US$/Unit) Table 152. China Phenprocoumon Sales Price by Type (2027-2032) & (US$/Unit) Table 153. China Phenprocoumon Revenue by Application (2021-2026) & (US$ Million) Table 154. China Phenprocoumon Revenue by Application (2027-2032) & (US$ Million) Table 155. China Phenprocoumon Sales by Application (2021-2026) & (K Units) Table 156. China Phenprocoumon Sales by Application (2027-2032) & (K Units) Table 157. China Phenprocoumon Sales Price by Application (2021-2026) & (US$/Unit) Table 158. China Phenprocoumon Sales Price by Application (2027-2032) & (US$/Unit) Table 159. Asia Phenprocoumon Revenue by Type (2021-2026) & (US$ Million) Table 160. Asia Phenprocoumon Revenue by Type (2027-2032) & (US$ Million) Table 161. Asia Phenprocoumon Sales by Type (2021-2026) & (K Units) Table 162. Asia Phenprocoumon Sales by Type (2027-2032) & (K Units) Table 163. Asia Phenprocoumon Sales Price by Type (2021-2026) & (US$/Unit) Table 164. Asia Phenprocoumon Sales Price by Type (2027-2032) & (US$/Unit) Table 165. Asia Phenprocoumon Revenue by Application (2021-2026) & (US$ Million) Table 166. Asia Phenprocoumon Revenue by Application (2027-2032) & (US$ Million) Table 167. Asia Phenprocoumon Sales by Application (2021-2026) & (K Units) Table 168. Asia Phenprocoumon Sales by Application (2027-2032) & (K Units) Table 169. Asia Phenprocoumon Sales Price by Application (2021-2026) & (US$/Unit) Table 170. Asia Phenprocoumon Sales Price by Application (2027-2032) & (US$/Unit) Table 171. Asia Phenprocoumon Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 172. Asia Phenprocoumon Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 173. Asia Phenprocoumon Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 174. Asia Phenprocoumon Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 175. Asia Phenprocoumon Sales by Country (2021-2026) & (K Units) Table 176. Asia Phenprocoumon Sales by Country (2027-2032) & (K Units) Table 177. Asia Phenprocoumon Sales Price by Country (2021-2026) & (US$/Unit) Table 178. Asia Phenprocoumon Sales Price by Country (2027-2032) & (US$/Unit) Table 179. Japan Phenprocoumon Revenue (2021-2032) & (US$ Million) Table 180. South Korea Phenprocoumon Revenue (2021-2032) & (US$ Million) Table 181. India Phenprocoumon Revenue (2021-2032) & (US$ Million) Table 182. Australia Phenprocoumon Revenue (2021-2032) & (US$ Million) Table 183. China Taiwan Phenprocoumon Revenue (2021-2032) & (US$ Million) Table 184. Southeast Asia Phenprocoumon Revenue (2021-2032) & (US$ Million) Table 185. SAMEA Phenprocoumon Revenue by Type (2021-2026) & (US$ Million) Table 186. SAMEA Phenprocoumon Revenue by Type (2027-2032) & (US$ Million) Table 187. SAMEA Phenprocoumon Sales by Type (2021-2026) & (K Units) Table 188. SAMEA Phenprocoumon Sales by Type (2027-2032) & (K Units) Table 189. SAMEA Phenprocoumon Sales Price by Type (2021-2026) & (US$/Unit) Table 190. SAMEA Phenprocoumon Sales Price by Type (2027-2032) & (US$/Unit) Table 191. SAMEA Phenprocoumon Revenue by Application (2021-2026) & (US$ Million) Table 192. SAMEA Phenprocoumon Revenue by Application (2027-2032) & (US$ Million) Table 193. SAMEA Phenprocoumon Sales by Application (2021-2026) & (K Units) Table 194. SAMEA Phenprocoumon Sales by Application (2027-2032) & (K Units) Table 195. SAMEA Phenprocoumon Sales Price by Application (2021-2026) & (US$/Unit) Table 196. SAMEA Phenprocoumon Sales Price by Application (2027-2032) & (US$/Unit) Table 197. SAMEA Phenprocoumon Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 198. SAMEA Phenprocoumon Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 199. SAMEA Phenprocoumon Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 200. SAMEA Phenprocoumon Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 201. SAMEA Phenprocoumon Sales by Country (2021-2026) & (K Units) Table 202. SAMEA Phenprocoumon Sales by Country (2027-2032) & (K Units) Table 203. SAMEA Phenprocoumon Sales Price by Country (2021-2026) & (US$/Unit) Table 204. SAMEA Phenprocoumon Sales Price by Country (2027-2032) & (US$/Unit) Table 205. Brazil Phenprocoumon Revenue (2021-2032) & (US$ Million) Table 206. Argentina Phenprocoumon Revenue (2021-2032) & (US$ Million) Table 207. Chile Phenprocoumon Revenue (2021-2032) & (US$ Million) Table 208. Colombia Phenprocoumon Revenue (2021-2032) & (US$ Million) Table 209. Peru Phenprocoumon Revenue (2021-2032) & (US$ Million) Table 210. Saudi Arabia Phenprocoumon Revenue (2021-2032) & (US$ Million) Table 211. Israel Phenprocoumon Revenue (2021-2032) & (US$ Million) Table 212. UAE Phenprocoumon Revenue (2021-2032) & (US$ Million) Table 213. Turkey Phenprocoumon Revenue (2021-2032) & (US$ Million) Table 214. Iran Phenprocoumon Revenue (2021-2032) & (US$ Million) Table 215. Egypt Phenprocoumon Revenue (2021-2032) & (US$ Million) Table 216. Key Raw Materials Table 217. Raw Materials Key Suppliers Table 218. Phenprocoumon Distributors List Table 219. Phenprocoumon Customers List Table 220. Research Programs/Design for This Report Table 221. Authors List of This Report Table 222. Secondary Sources Table 223. Primary Sources List of Figures Figure 1. Phenprocoumon Image Figure 2. Global Phenprocoumon Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Phenprocoumon Market Size Share 2021 VS 2025 VS 2032 Figure 4. 5 mg Image Figure 5. 10 mg Image Figure 6. 25 mg Image Figure 7. 50 mg Image Figure 8. Global Phenprocoumon Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Phenprocoumon Market Size Share 2021 VS 2025 VS 2032 Figure 10. Pulmonary Embolism Image Figure 11. Venous Thrombosis Image Figure 12. Thromboembolism Image Figure 13. Others Image Figure 14. Global Phenprocoumon Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Phenprocoumon Revenue (2021-2032) & (US$ Million) Figure 16. Global Phenprocoumon Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Phenprocoumon Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Phenprocoumon Revenue Market Share by Region (2021-2032) Figure 19. Global Phenprocoumon Sales (2021-2032) & (K Units) Figure 20. Global Phenprocoumon Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 21. Global Phenprocoumon Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Phenprocoumon Sales YoY (2021-2032) & (K Units) Figure 23. Europe Phenprocoumon Sales YoY (2021-2032) & (K Units) Figure 24. China Phenprocoumon Sales YoY (2021-2032) & (K Units) Figure 25. Asia (Excluding China) Phenprocoumon Sales YoY (2021-2032) & (K Units) Figure 26. South America, Middle East and Africa Phenprocoumon Sales YoY (2021-2032) & (K Units) Figure 27. Global Phenprocoumon Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Phenprocoumon Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Phenprocoumon Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Phenprocoumon Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Phenprocoumon Revenue Market Share by Type (2021-2032) Figure 33. Global Phenprocoumon Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 34. Global Phenprocoumon Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Phenprocoumon Sales Market Share by Type (2021-2032) Figure 36. Global Phenprocoumon Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Phenprocoumon Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Phenprocoumon Revenue Market Share by Application (2021-2032) Figure 39. Global Phenprocoumon Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 40. Global Phenprocoumon Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Phenprocoumon Sales Market Share by Application (2021-2032) Figure 42. North America Phenprocoumon Revenue Share by Type (2021-2032) Figure 43. North America Phenprocoumon Sales Share by Type (2021-2032) Figure 44. North America Phenprocoumon Revenue Share by Application (2021-2032) Figure 45. North America Phenprocoumon Sales Share by Application (2021-2032) Figure 46. North America Phenprocoumon Revenue Share by Country (2021-2032) Figure 47. North America Phenprocoumon Sales Share by Country (2021-2032) Figure 48. Europe Phenprocoumon Revenue Share by Type (2021-2032) Figure 49. Europe Phenprocoumon Sales Share by Type (2021-2032) Figure 50. Europe Phenprocoumon Revenue Share by Application (2021-2032) Figure 51. Europe Phenprocoumon Sales Share by Application (2021-2032) Figure 52. Europe Phenprocoumon Revenue Share by Country (2021-2032) Figure 53. Europe Phenprocoumon Sales Share by Country (2021-2032) Figure 54. China Phenprocoumon Revenue Share by Type (2021-2032) Figure 55. China Phenprocoumon Sales Share by Type (2021-2032) Figure 56. China Phenprocoumon Revenue Share by Application (2021-2032) Figure 57. China Phenprocoumon Sales Share by Application (2021-2032) Figure 58. Asia Phenprocoumon Revenue Share by Type (2021-2032) Figure 59. Asia Phenprocoumon Sales Share by Type (2021-2032) Figure 60. Asia Phenprocoumon Revenue Share by Application (2021-2032) Figure 61. Asia Phenprocoumon Sales Share by Application (2021-2032) Figure 62. Asia Phenprocoumon Revenue Share by Country (2021-2032) Figure 63. Asia Phenprocoumon Sales Share by Country (2021-2032) Figure 64. SAMEA Phenprocoumon Revenue Share by Type (2021-2032) Figure 65. SAMEA Phenprocoumon Sales Share by Type (2021-2032) Figure 66. SAMEA Phenprocoumon Revenue Share by Application (2021-2032) Figure 67. SAMEA Phenprocoumon Sales Share by Application (2021-2032) Figure 68. SAMEA Phenprocoumon Revenue Share by Country (2021-2032) Figure 69. SAMEA Phenprocoumon Sales Share by Country (2021-2032) Figure 70. Phenprocoumon Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Phenprocoumon Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • 5 mg
  • 10 mg
  • 25 mg
  • 50 mg
Applications
  • Pulmonary Embolism
  • Venous Thrombosis
  • Thromboembolism
  • Others
Companies covered
  • Teva
  • Novartis
  • Mylan
  • Roche
  • Wörwag Pharma
  • Divis Labs
  • Aspen Pharmacare
  • Acis Arzneimittel

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Phenprocoumon Market by Type
  3. 1.2.1 Global Phenprocoumon Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 5 mg
  5. 1.2.3 10 mg
  6. 1.2.4 25 mg
  7. 1.2.5 50 mg
  8. 1.3 Phenprocoumon Market by Application
  9. 1.3.1 Global Phenprocoumon Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Pulmonary Embolism
  11. 1.3.3 Venous Thrombosis
  12. 1.3.4 Thromboembolism
  13. 1.3.5 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Phenprocoumon Market Dynamics
  1. 2.1 Phenprocoumon Industry Trends
  2. 2.2 Phenprocoumon Industry Drivers
  3. 2.3 Phenprocoumon Industry Opportunities and Challenges
  4. 2.4 Phenprocoumon Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Phenprocoumon Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Phenprocoumon Revenue by Region
  3. 3.2.1 Global Phenprocoumon Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Phenprocoumon Revenue by Region (2021-2026)
  5. 3.2.3 Global Phenprocoumon Revenue by Region (2027-2032)
  6. 3.2.4 Global Phenprocoumon Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Phenprocoumon Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Phenprocoumon Sales by Region
  9. 3.4.1 Global Phenprocoumon Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Phenprocoumon Sales by Region (2021-2026)
  11. 3.4.3 Global Phenprocoumon Sales by Region (2027-2032)
  12. 3.4.4 Global Phenprocoumon Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Phenprocoumon Revenue by Manufacturers
  2. 4.1.1 Global Phenprocoumon Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Phenprocoumon Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Phenprocoumon Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Phenprocoumon Sales by Manufacturers
  6. 4.2.1 Global Phenprocoumon Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Phenprocoumon Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Phenprocoumon Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Phenprocoumon Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Phenprocoumon Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Phenprocoumon Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Phenprocoumon Manufacturers, Product Type & Application
  13. 4.7 Global Phenprocoumon Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Phenprocoumon Market CR5 and HHI
  16. 4.8.2 2025 Phenprocoumon Tier 1, Tier 2, and Tier 3
5 Phenprocoumon Market by Type
  1. 5.1 Global Phenprocoumon Revenue by Type
  2. 5.1.1 Global Phenprocoumon Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Phenprocoumon Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Phenprocoumon Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Phenprocoumon Sales by Type
  6. 5.2.1 Global Phenprocoumon Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Phenprocoumon Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Phenprocoumon Sales Market Share by Type (2021-2032)
  9. 5.3 Global Phenprocoumon Price by Type
6 Phenprocoumon Market by Application
  1. 6.1 Global Phenprocoumon Revenue by Application
  2. 6.1.1 Global Phenprocoumon Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Phenprocoumon Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Phenprocoumon Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Phenprocoumon Sales by Application
  6. 6.2.1 Global Phenprocoumon Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Phenprocoumon Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Phenprocoumon Sales Market Share by Application (2021-2032)
  9. 6.3 Global Phenprocoumon Price by Application
7 Company Profiles
  1. 7.1 Teva
  2. 7.1.1 Teva Company Information
  3. 7.1.2 Teva Business Overview
  4. 7.1.3 Teva Phenprocoumon Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Phenprocoumon Product Portfolio
  6. 7.1.5 Teva Recent Developments
  7. 7.2 Novartis
  8. 7.2.1 Novartis Company Information
  9. 7.2.2 Novartis Business Overview
  10. 7.2.3 Novartis Phenprocoumon Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Novartis Phenprocoumon Product Portfolio
  12. 7.2.5 Novartis Recent Developments
  13. 7.3 Mylan
  14. 7.3.1 Mylan Company Information
  15. 7.3.2 Mylan Business Overview
  16. 7.3.3 Mylan Phenprocoumon Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Mylan Phenprocoumon Product Portfolio
  18. 7.3.5 Mylan Recent Developments
  19. 7.4 Roche
  20. 7.4.1 Roche Company Information
  21. 7.4.2 Roche Business Overview
  22. 7.4.3 Roche Phenprocoumon Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Roche Phenprocoumon Product Portfolio
  24. 7.4.5 Roche Recent Developments
  25. 7.5 Wörwag Pharma
  26. 7.5.1 Wörwag Pharma Company Information
  27. 7.5.2 Wörwag Pharma Business Overview
  28. 7.5.3 Wörwag Pharma Phenprocoumon Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Wörwag Pharma Phenprocoumon Product Portfolio
  30. 7.5.5 Wörwag Pharma Recent Developments
  31. 7.6 Divis Labs
  32. 7.6.1 Divis Labs Company Information
  33. 7.6.2 Divis Labs Business Overview
  34. 7.6.3 Divis Labs Phenprocoumon Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Divis Labs Phenprocoumon Product Portfolio
  36. 7.6.5 Divis Labs Recent Developments
  37. 7.7 Aspen Pharmacare
  38. 7.7.1 Aspen Pharmacare Company Information
  39. 7.7.2 Aspen Pharmacare Business Overview
  40. 7.7.3 Aspen Pharmacare Phenprocoumon Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Aspen Pharmacare Phenprocoumon Product Portfolio
  42. 7.7.5 Aspen Pharmacare Recent Developments
  43. 7.8 Acis Arzneimittel
  44. 7.8.1 Acis Arzneimittel Company Information
  45. 7.8.2 Acis Arzneimittel Business Overview
  46. 7.8.3 Acis Arzneimittel Phenprocoumon Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Acis Arzneimittel Phenprocoumon Product Portfolio
  48. 7.8.5 Acis Arzneimittel Recent Developments
8 North America
  1. 8.1 North America Phenprocoumon Market Size by Type
  2. 8.1.1 North America Phenprocoumon Revenue by Type (2021-2032)
  3. 8.1.2 North America Phenprocoumon Sales by Type (2021-2032)
  4. 8.1.3 North America Phenprocoumon Price by Type (2021-2032)
  5. 8.2 North America Phenprocoumon Market Size by Application
  6. 8.2.1 North America Phenprocoumon Revenue by Application (2021-2032)
  7. 8.2.2 North America Phenprocoumon Sales by Application (2021-2032)
  8. 8.2.3 North America Phenprocoumon Price by Application (2021-2032)
  9. 8.3 North America Phenprocoumon Market Size by Country
  10. 8.3.1 North America Phenprocoumon Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Phenprocoumon Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Phenprocoumon Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Phenprocoumon Market Size by Type
  2. 9.1.1 Europe Phenprocoumon Revenue by Type (2021-2032)
  3. 9.1.2 Europe Phenprocoumon Sales by Type (2021-2032)
  4. 9.1.3 Europe Phenprocoumon Price by Type (2021-2032)
  5. 9.2 Europe Phenprocoumon Market Size by Application
  6. 9.2.1 Europe Phenprocoumon Revenue by Application (2021-2032)
  7. 9.2.2 Europe Phenprocoumon Sales by Application (2021-2032)
  8. 9.2.3 Europe Phenprocoumon Price by Application (2021-2032)
  9. 9.3 Europe Phenprocoumon Market Size by Country
  10. 9.3.1 Europe Phenprocoumon Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Phenprocoumon Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Phenprocoumon Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Phenprocoumon Market Size by Type
  2. 10.1.1 China Phenprocoumon Revenue by Type (2021-2032)
  3. 10.1.2 China Phenprocoumon Sales by Type (2021-2032)
  4. 10.1.3 China Phenprocoumon Price by Type (2021-2032)
  5. 10.2 China Phenprocoumon Market Size by Application
  6. 10.2.1 China Phenprocoumon Revenue by Application (2021-2032)
  7. 10.2.2 China Phenprocoumon Sales by Application (2021-2032)
  8. 10.2.3 China Phenprocoumon Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Phenprocoumon Market Size by Type
  2. 11.1.1 Asia Phenprocoumon Revenue by Type (2021-2032)
  3. 11.1.2 Asia Phenprocoumon Sales by Type (2021-2032)
  4. 11.1.3 Asia Phenprocoumon Price by Type (2021-2032)
  5. 11.2 Asia Phenprocoumon Market Size by Application
  6. 11.2.1 Asia Phenprocoumon Revenue by Application (2021-2032)
  7. 11.2.2 Asia Phenprocoumon Sales by Application (2021-2032)
  8. 11.2.3 Asia Phenprocoumon Price by Application (2021-2032)
  9. 11.3 Asia Phenprocoumon Market Size by Country
  10. 11.3.1 Asia Phenprocoumon Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Phenprocoumon Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Phenprocoumon Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Phenprocoumon Market Size by Type
  2. 12.1.1 SAMEA Phenprocoumon Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Phenprocoumon Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Phenprocoumon Price by Type (2021-2032)
  5. 12.2 SAMEA Phenprocoumon Market Size by Application
  6. 12.2.1 SAMEA Phenprocoumon Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Phenprocoumon Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Phenprocoumon Price by Application (2021-2032)
  9. 12.3 SAMEA Phenprocoumon Market Size by Country
  10. 12.3.1 SAMEA Phenprocoumon Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Phenprocoumon Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Phenprocoumon Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Phenprocoumon Value Chain Analysis
  2. 13.1.1 Phenprocoumon Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Phenprocoumon Production Mode & Process
  6. 13.2 Phenprocoumon Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Phenprocoumon Distributors
  9. 13.2.3 Phenprocoumon Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst